Doxazosin Tablet
Product Images NDC 70518-3965

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70518-3965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 01)
Chemical structure of the active ingredient Doxazosin, as depicted in the molecular diagram.*
FDA Label Image

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)

Doxazosin Tablets (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 02)
This figure presents study results comparing placebo and varying doses of doxazosin (4 mg and 8 mg) on symptom score and maximum flow rate in patients. It includes a bar graph for maximum flow rate changes from Study 2 and a table summarizing mean baseline and mean change for symptom score and maximum flow rate across three studies with placebo and doxazosin treatments.*
FDA Label Image

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)

Doxazosin Tablets, Usp (92ead971 9de8 4240 B2c7 Fc2e9abac7dd 03)
Two line graphs showing clinical study data for Doxazosin tablets 2 mg. The first graph depicts mean change in total symptom score from baseline over 14 weeks, comparing Doxazosin and placebo groups. The second graph shows mean increase in maximum urinary flow rate from baseline over the same duration. Data include error bars and statistical significance markers.*
FDA Label Image

Mm1 (Doxazosin 2mg 70518 3965 00)

Mm1 (Doxazosin 2mg 70518 3965 00)
Doxazosin Tablet 2 mg oral tablets packaging label for a quantity of 30 tablets. The label shows the labeler as RemedyRepack Inc., with repackaging location in Indiana, PA. Manufacturer information lists Zydus Pharm, Pennington, NJ. The label includes a National Drug Code (NDC) 70518-3965-00, storage instructions, and directions to see the insert for usual dosage.*
FDA Label Image

Mm2 (Doxazosin 2mg 70518 3965 01)

Mm2 (Doxazosin 2mg 70518 3965 01)
Doxazosin Tablet 2 mg label for a package containing 90 tablets. The label shows the NDC number 70518-3965-01, repackaged by RemedyRepack Inc., Indiana, PA. It includes storage instructions and mentions the manufacturer Zydus Pharm, Pennington, NJ. The tablets are round and pink.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.